0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmacogenetics Testing Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-17Y15398
Home | Market Reports | Science
Global Pharmacogenetics Testing Market Insights Forecast to 2029
BUY CHAPTERS

Global Pharmacogenetics Testing Market Research Report 2025

Code: QYRE-Auto-17Y15398
Report
January 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmacogenetics Testing Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmacogenetics Testing Market

Pharmacogenetics Testing Market

The global market for Pharmacogenetics Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pharmacogenetics testing is a type of genetic testing that analyzes an individual"s genetic makeup to determine how they may respond to certain medications. It involves studying the variations in genes that affect drug metabolism, efficacy, and potential side effects.
Pharmacogenetics testing can provide valuable information to healthcare professionals in determining the most effective and safe medications for a particular individual. By understanding an individual"s genetic variations, doctors can tailor drug prescriptions to match their specific genetic profile, potentially improving treatment outcomes and reducing the risk of adverse drug reactions.
This type of testing is particularly useful in determining the appropriate dosage of medications, predicting the likelihood of adverse drug reactions, and identifying individuals who may be poor responders to certain drugs. It can also help avoid trial-and-error approaches to medication selection, allowing for more personalized and precise treatment plans.
Pharmacogenetics testing is commonly used in various medical fields, including psychiatry, cardiology, oncology, and pain management. It is especially beneficial for medications with a narrow therapeutic index, where small variations in drug metabolism can significantly impact treatment outcomes.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmacogenetics Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacogenetics Testing.
The Pharmacogenetics Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmacogenetics Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacogenetics Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmacogenetics Testing Market Report

Report Metric Details
Report Name Pharmacogenetics Testing Market
CAGR 5%
Segment by Type
Segment by Application
  • Enterprise
  • Government
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Genetworx, ARUP Laboratories, Labcorp, Invitae, Clinical Labs, Abomics, Gravity Diagnostics, Carolina Pharmacy, Kailos Genetics, Fulgent Genetics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmacogenetics Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmacogenetics Testing Market report?

Ans: The main players in the Pharmacogenetics Testing Market are Genetworx, ARUP Laboratories, Labcorp, Invitae, Clinical Labs, Abomics, Gravity Diagnostics, Carolina Pharmacy, Kailos Genetics, Fulgent Genetics

What are the Application segmentation covered in the Pharmacogenetics Testing Market report?

Ans: The Applications covered in the Pharmacogenetics Testing Market report are Enterprise, Government

What are the Type segmentation covered in the Pharmacogenetics Testing Market report?

Ans: The Types covered in the Pharmacogenetics Testing Market report are Dosage Selection, Adverse Reaction Assessment

Recommended Reports

Pharmacogenomics & Genetic Testing

Drug Discovery & Therapy

Pharmaceutical Safety & QA

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacogenetics Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Dosage Selection
1.2.3 Adverse Reaction Assessment
1.3 Market by Application
1.3.1 Global Pharmacogenetics Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Enterprise
1.3.3 Government
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacogenetics Testing Market Perspective (2020-2031)
2.2 Global Pharmacogenetics Testing Growth Trends by Region
2.2.1 Global Pharmacogenetics Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmacogenetics Testing Historic Market Size by Region (2020-2025)
2.2.3 Pharmacogenetics Testing Forecasted Market Size by Region (2026-2031)
2.3 Pharmacogenetics Testing Market Dynamics
2.3.1 Pharmacogenetics Testing Industry Trends
2.3.2 Pharmacogenetics Testing Market Drivers
2.3.3 Pharmacogenetics Testing Market Challenges
2.3.4 Pharmacogenetics Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacogenetics Testing Players by Revenue
3.1.1 Global Top Pharmacogenetics Testing Players by Revenue (2020-2025)
3.1.2 Global Pharmacogenetics Testing Revenue Market Share by Players (2020-2025)
3.2 Global Pharmacogenetics Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmacogenetics Testing Revenue
3.4 Global Pharmacogenetics Testing Market Concentration Ratio
3.4.1 Global Pharmacogenetics Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacogenetics Testing Revenue in 2024
3.5 Global Key Players of Pharmacogenetics Testing Head office and Area Served
3.6 Global Key Players of Pharmacogenetics Testing, Product and Application
3.7 Global Key Players of Pharmacogenetics Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacogenetics Testing Breakdown Data by Type
4.1 Global Pharmacogenetics Testing Historic Market Size by Type (2020-2025)
4.2 Global Pharmacogenetics Testing Forecasted Market Size by Type (2026-2031)
5 Pharmacogenetics Testing Breakdown Data by Application
5.1 Global Pharmacogenetics Testing Historic Market Size by Application (2020-2025)
5.2 Global Pharmacogenetics Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmacogenetics Testing Market Size (2020-2031)
6.2 North America Pharmacogenetics Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmacogenetics Testing Market Size by Country (2020-2025)
6.4 North America Pharmacogenetics Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacogenetics Testing Market Size (2020-2031)
7.2 Europe Pharmacogenetics Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmacogenetics Testing Market Size by Country (2020-2025)
7.4 Europe Pharmacogenetics Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacogenetics Testing Market Size (2020-2031)
8.2 Asia-Pacific Pharmacogenetics Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmacogenetics Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmacogenetics Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacogenetics Testing Market Size (2020-2031)
9.2 Latin America Pharmacogenetics Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmacogenetics Testing Market Size by Country (2020-2025)
9.4 Latin America Pharmacogenetics Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacogenetics Testing Market Size (2020-2031)
10.2 Middle East & Africa Pharmacogenetics Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmacogenetics Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmacogenetics Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genetworx
11.1.1 Genetworx Company Details
11.1.2 Genetworx Business Overview
11.1.3 Genetworx Pharmacogenetics Testing Introduction
11.1.4 Genetworx Revenue in Pharmacogenetics Testing Business (2020-2025)
11.1.5 Genetworx Recent Development
11.2 ARUP Laboratories
11.2.1 ARUP Laboratories Company Details
11.2.2 ARUP Laboratories Business Overview
11.2.3 ARUP Laboratories Pharmacogenetics Testing Introduction
11.2.4 ARUP Laboratories Revenue in Pharmacogenetics Testing Business (2020-2025)
11.2.5 ARUP Laboratories Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Details
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Pharmacogenetics Testing Introduction
11.3.4 Labcorp Revenue in Pharmacogenetics Testing Business (2020-2025)
11.3.5 Labcorp Recent Development
11.4 Invitae
11.4.1 Invitae Company Details
11.4.2 Invitae Business Overview
11.4.3 Invitae Pharmacogenetics Testing Introduction
11.4.4 Invitae Revenue in Pharmacogenetics Testing Business (2020-2025)
11.4.5 Invitae Recent Development
11.5 Clinical Labs
11.5.1 Clinical Labs Company Details
11.5.2 Clinical Labs Business Overview
11.5.3 Clinical Labs Pharmacogenetics Testing Introduction
11.5.4 Clinical Labs Revenue in Pharmacogenetics Testing Business (2020-2025)
11.5.5 Clinical Labs Recent Development
11.6 Abomics
11.6.1 Abomics Company Details
11.6.2 Abomics Business Overview
11.6.3 Abomics Pharmacogenetics Testing Introduction
11.6.4 Abomics Revenue in Pharmacogenetics Testing Business (2020-2025)
11.6.5 Abomics Recent Development
11.7 Gravity Diagnostics
11.7.1 Gravity Diagnostics Company Details
11.7.2 Gravity Diagnostics Business Overview
11.7.3 Gravity Diagnostics Pharmacogenetics Testing Introduction
11.7.4 Gravity Diagnostics Revenue in Pharmacogenetics Testing Business (2020-2025)
11.7.5 Gravity Diagnostics Recent Development
11.8 Carolina Pharmacy
11.8.1 Carolina Pharmacy Company Details
11.8.2 Carolina Pharmacy Business Overview
11.8.3 Carolina Pharmacy Pharmacogenetics Testing Introduction
11.8.4 Carolina Pharmacy Revenue in Pharmacogenetics Testing Business (2020-2025)
11.8.5 Carolina Pharmacy Recent Development
11.9 Kailos Genetics
11.9.1 Kailos Genetics Company Details
11.9.2 Kailos Genetics Business Overview
11.9.3 Kailos Genetics Pharmacogenetics Testing Introduction
11.9.4 Kailos Genetics Revenue in Pharmacogenetics Testing Business (2020-2025)
11.9.5 Kailos Genetics Recent Development
11.10 Fulgent Genetics
11.10.1 Fulgent Genetics Company Details
11.10.2 Fulgent Genetics Business Overview
11.10.3 Fulgent Genetics Pharmacogenetics Testing Introduction
11.10.4 Fulgent Genetics Revenue in Pharmacogenetics Testing Business (2020-2025)
11.10.5 Fulgent Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Pharmacogenetics Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Dosage Selection
 Table 3. Key Players of Adverse Reaction Assessment
 Table 4. Global Pharmacogenetics Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Pharmacogenetics Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pharmacogenetics Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Pharmacogenetics Testing Market Share by Region (2020-2025)
 Table 8. Global Pharmacogenetics Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Pharmacogenetics Testing Market Share by Region (2026-2031)
 Table 10. Pharmacogenetics Testing Market Trends
 Table 11. Pharmacogenetics Testing Market Drivers
 Table 12. Pharmacogenetics Testing Market Challenges
 Table 13. Pharmacogenetics Testing Market Restraints
 Table 14. Global Pharmacogenetics Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Pharmacogenetics Testing Market Share by Players (2020-2025)
 Table 16. Global Top Pharmacogenetics Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenetics Testing as of 2024)
 Table 17. Ranking of Global Top Pharmacogenetics Testing Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Pharmacogenetics Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Pharmacogenetics Testing, Headquarters and Area Served
 Table 20. Global Key Players of Pharmacogenetics Testing, Product and Application
 Table 21. Global Key Players of Pharmacogenetics Testing, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Pharmacogenetics Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Pharmacogenetics Testing Revenue Market Share by Type (2020-2025)
 Table 25. Global Pharmacogenetics Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Pharmacogenetics Testing Revenue Market Share by Type (2026-2031)
 Table 27. Global Pharmacogenetics Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Pharmacogenetics Testing Revenue Market Share by Application (2020-2025)
 Table 29. Global Pharmacogenetics Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Pharmacogenetics Testing Revenue Market Share by Application (2026-2031)
 Table 31. North America Pharmacogenetics Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Pharmacogenetics Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Pharmacogenetics Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Pharmacogenetics Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Pharmacogenetics Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Pharmacogenetics Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Pharmacogenetics Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Pharmacogenetics Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Pharmacogenetics Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pharmacogenetics Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Pharmacogenetics Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Pharmacogenetics Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Pharmacogenetics Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Pharmacogenetics Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Pharmacogenetics Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Genetworx Company Details
 Table 47. Genetworx Business Overview
 Table 48. Genetworx Pharmacogenetics Testing Product
 Table 49. Genetworx Revenue in Pharmacogenetics Testing Business (2020-2025) & (US$ Million)
 Table 50. Genetworx Recent Development
 Table 51. ARUP Laboratories Company Details
 Table 52. ARUP Laboratories Business Overview
 Table 53. ARUP Laboratories Pharmacogenetics Testing Product
 Table 54. ARUP Laboratories Revenue in Pharmacogenetics Testing Business (2020-2025) & (US$ Million)
 Table 55. ARUP Laboratories Recent Development
 Table 56. Labcorp Company Details
 Table 57. Labcorp Business Overview
 Table 58. Labcorp Pharmacogenetics Testing Product
 Table 59. Labcorp Revenue in Pharmacogenetics Testing Business (2020-2025) & (US$ Million)
 Table 60. Labcorp Recent Development
 Table 61. Invitae Company Details
 Table 62. Invitae Business Overview
 Table 63. Invitae Pharmacogenetics Testing Product
 Table 64. Invitae Revenue in Pharmacogenetics Testing Business (2020-2025) & (US$ Million)
 Table 65. Invitae Recent Development
 Table 66. Clinical Labs Company Details
 Table 67. Clinical Labs Business Overview
 Table 68. Clinical Labs Pharmacogenetics Testing Product
 Table 69. Clinical Labs Revenue in Pharmacogenetics Testing Business (2020-2025) & (US$ Million)
 Table 70. Clinical Labs Recent Development
 Table 71. Abomics Company Details
 Table 72. Abomics Business Overview
 Table 73. Abomics Pharmacogenetics Testing Product
 Table 74. Abomics Revenue in Pharmacogenetics Testing Business (2020-2025) & (US$ Million)
 Table 75. Abomics Recent Development
 Table 76. Gravity Diagnostics Company Details
 Table 77. Gravity Diagnostics Business Overview
 Table 78. Gravity Diagnostics Pharmacogenetics Testing Product
 Table 79. Gravity Diagnostics Revenue in Pharmacogenetics Testing Business (2020-2025) & (US$ Million)
 Table 80. Gravity Diagnostics Recent Development
 Table 81. Carolina Pharmacy Company Details
 Table 82. Carolina Pharmacy Business Overview
 Table 83. Carolina Pharmacy Pharmacogenetics Testing Product
 Table 84. Carolina Pharmacy Revenue in Pharmacogenetics Testing Business (2020-2025) & (US$ Million)
 Table 85. Carolina Pharmacy Recent Development
 Table 86. Kailos Genetics Company Details
 Table 87. Kailos Genetics Business Overview
 Table 88. Kailos Genetics Pharmacogenetics Testing Product
 Table 89. Kailos Genetics Revenue in Pharmacogenetics Testing Business (2020-2025) & (US$ Million)
 Table 90. Kailos Genetics Recent Development
 Table 91. Fulgent Genetics Company Details
 Table 92. Fulgent Genetics Business Overview
 Table 93. Fulgent Genetics Pharmacogenetics Testing Product
 Table 94. Fulgent Genetics Revenue in Pharmacogenetics Testing Business (2020-2025) & (US$ Million)
 Table 95. Fulgent Genetics Recent Development
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources
 Table 99. Authors List of This Report


List of Figures
 Figure 1. Pharmacogenetics Testing Picture
 Figure 2. Global Pharmacogenetics Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmacogenetics Testing Market Share by Type: 2024 VS 2031
 Figure 4. Dosage Selection Features
 Figure 5. Adverse Reaction Assessment Features
 Figure 6. Global Pharmacogenetics Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pharmacogenetics Testing Market Share by Application: 2024 VS 2031
 Figure 8. Enterprise Case Studies
 Figure 9. Government Case Studies
 Figure 10. Pharmacogenetics Testing Report Years Considered
 Figure 11. Global Pharmacogenetics Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Pharmacogenetics Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pharmacogenetics Testing Market Share by Region: 2024 VS 2031
 Figure 14. Global Pharmacogenetics Testing Market Share by Players in 2024
 Figure 15. Global Top Pharmacogenetics Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenetics Testing as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Pharmacogenetics Testing Revenue in 2024
 Figure 17. North America Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Pharmacogenetics Testing Market Share by Country (2020-2031)
 Figure 19. United States Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Pharmacogenetics Testing Market Share by Country (2020-2031)
 Figure 23. Germany Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Pharmacogenetics Testing Market Share by Region (2020-2031)
 Figure 31. China Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Pharmacogenetics Testing Market Share by Country (2020-2031)
 Figure 39. Mexico Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Pharmacogenetics Testing Market Share by Country (2020-2031)
 Figure 43. Turkey Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Pharmacogenetics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Genetworx Revenue Growth Rate in Pharmacogenetics Testing Business (2020-2025)
 Figure 47. ARUP Laboratories Revenue Growth Rate in Pharmacogenetics Testing Business (2020-2025)
 Figure 48. Labcorp Revenue Growth Rate in Pharmacogenetics Testing Business (2020-2025)
 Figure 49. Invitae Revenue Growth Rate in Pharmacogenetics Testing Business (2020-2025)
 Figure 50. Clinical Labs Revenue Growth Rate in Pharmacogenetics Testing Business (2020-2025)
 Figure 51. Abomics Revenue Growth Rate in Pharmacogenetics Testing Business (2020-2025)
 Figure 52. Gravity Diagnostics Revenue Growth Rate in Pharmacogenetics Testing Business (2020-2025)
 Figure 53. Carolina Pharmacy Revenue Growth Rate in Pharmacogenetics Testing Business (2020-2025)
 Figure 54. Kailos Genetics Revenue Growth Rate in Pharmacogenetics Testing Business (2020-2025)
 Figure 55. Fulgent Genetics Revenue Growth Rate in Pharmacogenetics Testing Business (2020-2025)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Ecology Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29H6022
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Robotics Paint Booth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3R7922
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart